Overview
The maturation of GABAA receptor-mediated signaling from depolarizing to inhibitory is an age-related process controlled by cation chloride cotransporters, such as KCC2. As a result, GABA exerts dual functions, being an important neurotrophic factor during early development and the principal inhibitory neurotransmitter of the mature central nervous system. In our laboratory we have been investigating the age and mechanisms through which early life stressors and seizures may disrupt the normal patterns of brain development, by disrupting the neurotrophic effects of GABA. We are also studying methods to reverse these adverse processes. Furthermore, we are very interested in understanding how epileptogenesis proceeds in the developing brain and what is the specific role of GABAA receptors in this process.
Dr. Galanopoulou is rated as an Experienced provider by MediFind in the treatment of Neurotoxicity Syndromes. Her top areas of expertise are West Syndrome, Spasmus Nutans, Post-Traumatic Epilepsy, and Epilepsy.
Her clinical research consists of co-authoring 129 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Neurotoxicity Syndromes.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- MEDICARE SNP
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- PPO
- EPO
- HMO
- PPO
- MEDICARE-MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
111 East 210th Street, Bronx, NY 10461
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Memorial Neurology Group
Bianca Santomasso is a Neurologist in New York, New York. Dr. Santomasso has been practicing medicine for over 18 years and is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. Her top areas of expertise are Neurotoxicity Syndromes, Primary Lymphoma of the Brain, Brain Tumor, and Metastatic Brain Tumor.
Nassau Health Care Corporation
Daniel Rubin is a Neurologist in East Meadow, New York. Dr. Rubin is rated as an Advanced provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Neurotoxicity Syndromes, Cerebelloolivary Atrophy, Primary Familial Brain Calcification, and Olivopontocerebellar Atrophy.
Garden State Neurology & Neuro-Oncology
Sumul Raval is a Neurologist in West Long Branch, New Jersey. Dr. Raval is rated as a Distinguished provider by MediFind in the treatment of Neurotoxicity Syndromes. His top areas of expertise are Meningioma, Posterior Fossa Tumor, Radiation Induced Meningioma, and Astrocytoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- EpilepsyDr. Galanopoulou isElite. Learn about Epilepsy.
- Post-Traumatic EpilepsyDr. Galanopoulou isElite. Learn about Post-Traumatic Epilepsy.
- Spasmus NutansDr. Galanopoulou isElite. Learn about Spasmus Nutans.
- West SyndromeDr. Galanopoulou isElite. Learn about West Syndrome.
- Distinguished
- Epilepsy in ChildrenDr. Galanopoulou isDistinguished. Learn about Epilepsy in Children.
- SeizuresDr. Galanopoulou isDistinguished. Learn about Seizures.
- Advanced
- Absence SeizureDr. Galanopoulou isAdvanced. Learn about Absence Seizure.
- Generalized Tonic-Clonic SeizureDr. Galanopoulou isAdvanced. Learn about Generalized Tonic-Clonic Seizure.
- Myoclonic EpilepsyDr. Galanopoulou isAdvanced. Learn about Myoclonic Epilepsy.
- Experienced
- Autism Spectrum DisorderDr. Galanopoulou isExperienced. Learn about Autism Spectrum Disorder.
- Cortical DysplasiaDr. Galanopoulou isExperienced. Learn about Cortical Dysplasia.
- EncephalitisDr. Galanopoulou isExperienced. Learn about Encephalitis.
- Epilepsy with Myoclonic-Atonic SeizuresDr. Galanopoulou isExperienced. Learn about Epilepsy with Myoclonic-Atonic Seizures.
- Genetic Epilepsy with Febrile Seizures Plus (GEFS+)Dr. Galanopoulou isExperienced. Learn about Genetic Epilepsy with Febrile Seizures Plus (GEFS+).
- Lennox-Gastaut Syndrome (LGS)Dr. Galanopoulou isExperienced. Learn about Lennox-Gastaut Syndrome (LGS).